COVID-19 Pandemic Impact
Cross-source consensus on COVID-19 Pandemic Impact from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Risks & contraindications
Comparisons
Background
Highlighted claims
- The annual percentage change in age-standardised prevalence rate reached −2.32 during 2019–2021, the steepest single-segment decline identified by Joinpoint regression. — Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study
- The authors recommend integrating remote IOP monitoring and chronic eye disease management into public health emergency preparedness plans to prevent service disruption during future crises. — Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study
- The COVID-19 pandemic period produced the most pronounced deceleration in glaucoma burden growth across the entire 1990–2021 study window. — Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study
- The pandemic deceleration likely reflects excess elderly mortality, temporary suspension of non-emergency ophthalmic services, and delayed case presentations rather than true disease reduction. — Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study
- Post-pandemic diagnostic catch-up could transiently inflate recorded incidence rates, requiring continuous monitoring. — Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study